These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37525483)

  • 1. First case report of serous otitis media as a complication of severe ovarian hyperstimulation syndrome: Case report and literature review.
    Santistevan L; Lonergan D; Eyvazzadeh AD
    Int J Gynaecol Obstet; 2024 Mar; 164(3):843-847. PubMed ID: 37525483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low-dose aspirin on the development of ovarian hyperstimulation syndrome and outcomes of assisted reproductive techniques in the women with PCOS, a randomized double-blinded clinical trial.
    Namavar Jahromi B; Zolghadri J; Rahmani E; Alipour S; Anvar Z; Zarei A; Keramati P
    Taiwan J Obstet Gynecol; 2019 Mar; 58(2):255-260. PubMed ID: 30910149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsuspected adverse effect of albumin in severe ovarian hyperstimulation syndrome: a case report.
    Darii N; Pavlovic M; Doroftei B; Emil A
    JBRA Assist Reprod; 2019 Oct; 23(4):430-433. PubMed ID: 31058477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency ultrasound diagnosis of ovarian hyperstimulation syndrome: case report.
    Frasure SE; Rempell JS; Noble VE; Liteplo AS
    J Emerg Med; 2012 Aug; 43(2):e129-32. PubMed ID: 22525699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevention of ovarian hyperstimulation syndrome.
    Corbett S; Shmorgun D; Claman P; ;
    J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian hyperstimulation syndrome: facts and fallacies.
    Beerendonk CC; van Dop PA; Braat DD; Merkus JM
    Obstet Gynecol Surv; 1998 Jul; 53(7):439-49. PubMed ID: 9662730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive ventilation for the treatment of acute respiratory failure following ovarian hyperstimulation syndrome: report of two cases and a brief review of the literature.
    Barlascini C; Piroddi MG; Perazzo A; Senarega R; Santo M; Nicolini A
    Pneumologia; 2015; 64(2):30-4. PubMed ID: 26506672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
    Rizk B; Aboulghar M; Smitz J; Ron-El R
    Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion.
    Semba S; Moriya T; Youssef EM; Sasano H
    Pathol Int; 2000 Jul; 50(7):549-52. PubMed ID: 10886738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger and freeze-all strategy in GnRH antagonist protocol; case report and literature review.
    Hajizadeh N; Hosseini S; Salehpour S; Abbasi H; Saheb J
    JBRA Assist Reprod; 2023 Jun; 27(2):325-327. PubMed ID: 36749812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
    Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
    Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whether Letrozole could reduce the incidence of early ovary hyperstimulation syndrome after assisted reproductive technology? A systematic review and meta-analysis.
    Zhao J; Xu B; Huang X; Yan Y; Li Y
    Reprod Health; 2020 Nov; 17(1):181. PubMed ID: 33218353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis.
    Smith LP; Hacker MR; Alper MM
    Fertil Steril; 2009 Dec; 92(6):1953-9. PubMed ID: 18976762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review.
    Velthuis E; Hubbard J; Longobardi S; D'Hooghe T
    Adv Ther; 2020 Dec; 37(12):4831-4847. PubMed ID: 33058045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome.
    Mathur R; Kailasam C; Jenkins J
    Hum Fertil (Camb); 2007 Jun; 10(2):75-85. PubMed ID: 17564886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes.
    Schirmer DA; Kulkarni AD; Zhang Y; Kawwass JF; Boulet SL; Kissin DM
    Fertil Steril; 2020 Sep; 114(3):567-578. PubMed ID: 32680613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome.
    Ozgun MT; Batukan C; Oner G; Uludag S; Aygen EM; Sahin Y
    Gynecol Endocrinol; 2008 Nov; 24(11):656-8. PubMed ID: 19031224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent megalocystic ovary following in vitro fertilization in a postpartum patient with polycystic ovarian syndrome.
    Ling SY; Chong KM; Hwang JL
    Taiwan J Obstet Gynecol; 2006 Mar; 45(1):70-2. PubMed ID: 17272214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome.
    Lainas GT; Lainas TG; Venetis CA; Sfontouris IA; Zorzovilis IZ; Alexopoulou E; Tarlatzis BC; Kolibianakis EM
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):126-133. PubMed ID: 29105961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.